Teva Pharmaceutical Industries Limited (TEVA)

NYSE: TEVA · Real-Time Price · USD

32.28

-1.49 (-4.41%)

At close: Mar 3, 2026, 4:00 PM EST

33.46

+1.18 (3.66%)

Pre-market: Mar 4, 2026, 8:44 AM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
UNITED STATES	9.19B	8.03B	7.73B	7.00B	-
UNITED STATES Growth	14.34%	3.92%	10.40%	-	-
Other Activities	870.00M	944.00M	926.00M	1.05B	1.15B
Other Activities Growth	-7.84%	1.94%	-11.39%	-9.21%	-11.60%
Europe	5.04B	5.10B	4.84B	4.53B	4.89B
Europe Growth	-1.23%	5.50%	6.90%	-7.39%	2.71%
International Markets	2.16B	2.46B	2.35B	2.35B	2.03B
International Markets Growth	-12.22%	4.76%	-0.04%	15.75%	-5.66%
North America	-	-	-	-	7.81B
North America Growth	-	-	-	-	-7.55%
Total	17.26B	16.54B	15.85B	14.93B	15.88B
Total Growth	4.32%	4.41%	6.16%	-6.00%	-4.69%

Source: S&P Global Market Intelligence.